tiprankstipranks

Huw Jones Insider Profile

4 Followers
Huw Jones, Chief Executive Officer at Evgen Pharma, holds 3.18M shares in Evgen Pharma (Ticker: GB:TCF).
tipranks
Huw  Jones

Huw Jones
Evgen Pharma (TCF)
Chief Executive Officer

Ranked #75,328 out of 97,997 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-35.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

£25K
100.00%
A breakdown of Huw Jones's holdings

Insider Roles

Evgen Pharma
(TCF)
Chief Executive Officer
Roles that Huw Jones holds in companies

Most Profitable Insider Trade

Stock:
Evgen Pharma
(TCF)
Rating:Informative Buy
Date:Mar 20, 2024 - Today
Return:-17.90%
The most profitable trade made by Huw Jones

Huw Jones's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Evgen Pharma
Apr 05, 2024
Chief Executive Officer
Uninformative Buy
1.76K
£25.48K
Success Rate for
TCF
0 out of 2 profitable transactions on
TCF
0%
Average Return for
TCF
Average return per transaction on
TCF
-35.60%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 02, 2021
Informative Buy
£5.00K
-
£8.00
-53.30%
Mar 20, 2024
Informative Buy
£30.00K
-
£1.00
-17.90%
Apr 05, 2024
Uninformative Buy
£1.76K
-
£1.00
List of latest transactions for each holding click on a transaction to see Huw Jones's performance on stock

Huw Jones insider profile FAQ

What is the percentage of profitable transactions made by Huw Jones?
The percentage of profitable transactions made by Huw Jones is 0%.
    What is the average return per transaction made by Huw Jones?
    The average return per transaction made by Huw Jones is -35.60%.
      What stocks does Huw Jones hold?
      Huw Jones holds: GB:TCF stocks.
        What was Huw Jones’s latest transaction?
        Huw Jones latest transaction was an Uninformative Buy of 1.76K.
          What was Huw Jones's most profitable transaction?
          Huw Jones’s most profitable transaction was an Informative Buy of GB:TCF stock on March 20, 2024. The return on the trade was -17.90%.
            What is Huw Jones's role in Evgen Pharma?
            Huw Jones's role in Evgen Pharma is Chief Executive Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.